Molecular Imaging in the Evaluation of 6 Doses of Ra-223 in High-Grade Prostate Cancer: Case Report

Clin Genitourin Cancer. 2017 Feb;15(1):e159-e164. doi: 10.1016/j.clgc.2016.05.014. Epub 2016 May 27.
No abstract available

Keywords: High-grade prostate cancer; NaF; PET/CT; PSMA; Radium-223.

Publication types

  • Case Reports

MeSH terms

  • Antigens, Surface / metabolism
  • Clinical Trials, Phase III as Topic
  • Glutamate Carboxypeptidase II / metabolism
  • Humans
  • Male
  • Middle Aged
  • Molecular Imaging / methods*
  • Positron Emission Tomography Computed Tomography
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / metabolism
  • Radiopharmaceuticals / administration & dosage*
  • Radium / administration & dosage*

Substances

  • Antigens, Surface
  • Radiopharmaceuticals
  • Radium-223
  • FOLH1 protein, human
  • Glutamate Carboxypeptidase II
  • Radium